Tanaka Miyuki, Misawa Eriko, Ito Yousuke, Habara Noriko, Nomaguchi Kouji, Yamada Muneo, Toida Tomohiro, Hayasawa Hirotoshi, Takase Mitunori, Inagaki Masanori, Higuchi Ryuuichi
Biochemical Research Laboratory, Morinaga Milk Industry Co., Ltd, Kanagawa, Japan.
Biol Pharm Bull. 2006 Jul;29(7):1418-22. doi: 10.1248/bpb.29.1418.
The genus Aloe in the family Liliaceae is a group of plants including Aloe vera (Aloe barbadensis MILLER) and Aloe arborescens (Aloe arborescens MILLER var. natalensis BERGER) that are empirically known to have various medical efficacies. In the present study, we evaluated the anti-hyperglycemic effect of Aloe vera gel and isolated a number of compounds from the gel. On the basis of spectroscopic data, these compounds were identified as lophenol, 24-methyl-lophenol, 24-ethyl-lophenol, cycloartanol, and 24-methylene-cycloartanol. These five phytosterols were evaluated for their anti-hyperglycemic effects in type 2 diabetic BKS.Cg-m(+/+)Lepr(db/J) (db/db) mice. In comparison with the hemoglobin A1c (HbA1c) levels of vehicle-treated mice, statistically significant decreases of 15 to 18% in HbA1c levels were observed in mice treated with 1 mug of the five phytosterols. Considering the ability to reduce blood glucose in vivo, there were no differences between the five phytosterols. Administration of beta-sitosterol did not reduce the blood glucose levels in db/db mice. After administration of the five phytosterols for 28 d, fasting blood glucose levels decreased to approximately 64%, 28%, 47%, 51%, and 55% of control levels, respectively. Severe diabetic mice treated with phytosterols derived from Aloe vera gel did not suffer weight reduction due to glucose loss in the urine. These findings suggest that Aloe vera gel and phytosterols derived from Aloe vera gel have a long-term blood glucose level control effect and would be useful for the treatment of type 2 diabetes mellitus.
百合科芦荟属是一组植物,包括库拉索芦荟(Aloe barbadensis MILLER)和木立芦荟(Aloe arborescens MILLER var. natalensis BERGER),根据经验可知它们具有多种医学功效。在本研究中,我们评估了库拉索芦荟凝胶的降血糖作用,并从该凝胶中分离出了多种化合物。根据光谱数据,这些化合物被鉴定为洛酚、24-甲基-洛酚、24-乙基-洛酚、环阿屯醇和24-亚甲基-环阿屯醇。对这五种植物甾醇在2型糖尿病BKS.Cg-m(+/+)Lepr(db/J)(db/db)小鼠中的降血糖作用进行了评估。与载体处理小鼠的糖化血红蛋白(HbA1c)水平相比,用1微克这五种植物甾醇处理的小鼠HbA1c水平在统计学上显著降低了15%至18%。考虑到体内降低血糖的能力,这五种植物甾醇之间没有差异。给予β-谷甾醇并未降低db/db小鼠的血糖水平。给予这五种植物甾醇28天后,空腹血糖水平分别降至对照水平的约64%、28%、47%、51%和55%。用库拉索芦荟凝胶衍生的植物甾醇治疗的重度糖尿病小鼠没有因尿糖导致体重减轻。这些发现表明,库拉索芦荟凝胶和库拉索芦荟凝胶衍生的植物甾醇具有长期控制血糖水平的作用,对2型糖尿病的治疗可能有用。